DavidGriffithSoergelMD

Pediatric Heart Failure and Heart Transplantation

Physician

Dr. Soergel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

95 citations
First clinical experience with TRV130: pharmacokinetics and pharmacodynamics in healthy volunteers.
David G. Soergel, Ruth Ann Subach, Brian M. Sadler, John Connell, Alan S. Marion
Journal of Clinical Pharmacology. 2014-03-01
33 citations
Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of B...
Gad Cotter, Beth A. Davison, Javed Butler, Sean P. Collins, Justin A. Ezekowitz
Clinical Research in Cardiology. 2018-02-01
63 citations
First Clinical Experience with TRV027: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
David G. Soergel, Ruth Ann Subach, Conrad L. Cowan, Jonathan D. Violin, Michael W. Lark
Journal of Clinical Pharmacology. 2013-09-01

Novartis Oral Fabhalta® (Iptacopan) Sustained Clinically Meaningful Results at One Year in Phase III C3 Glomerulopathy (C3G) TrialOctober 26th, 2024
Novartis Entresto Receives Positive CHMP Opinion for Pediatric Heart FailureApril 1st, 2023
Novartis Entresto Receives Positive CHMP Opinion for Pediatric Heart FailureMarch 31st, 2023
Join now to see all